Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

Major Salivary Glands Tumors：A 10-Year Experience

주 타액선 종양에 대한 10년 간의 경험

  • Kong, Il-Gyu (Departments of Otorhinolaryngology-Head & Neck Surgery, Seoul National University College of Medicine) ;
  • Chang, Dong-Yeop (Departments of Otorhinolaryngology-Head & Neck Surgery, Seoul National University College of Medicine) ;
  • Jung, Eun-Jung (Departments of Otorhinolaryngology-Head & Neck Surgery, Seoul National University College of Medicine) ;
  • Jung, Young-Ho (Departments of Otorhinolaryngology-Head & Neck Surgery, Seoul National University College of Medicine) ;
  • Hah, J.Hun (Departments of Otorhinolaryngology-Head & Neck Surgery, Seoul National University College of Medicine) ;
  • Sung, Myung-Whun (Departments of Otorhinolaryngology-Head & Neck Surgery, Seoul National University College of Medicine) ;
  • Kim, Kwang-Hyun (Departments of Otorhinolaryngology-Head & Neck Surgery, Seoul National University College of Medicine)
  • 공일규 (서울대학교 의과대학 이비인후과학교실) ;
  • 장동엽 (서울대학교 의과대학 이비인후과학교실) ;
  • 정은정 (서울대학교 의과대학 이비인후과학교실) ;
  • 정영호 (서울대학교 의과대학 이비인후과학교실) ;
  • 하정훈 (서울대학교 의과대학 이비인후과학교실) ;
  • 성명훈 (서울대학교 의과대학 이비인후과학교실) ;
  • 김광현 (서울대학교 의과대학 이비인후과학교실)
  • Published : 2006.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background and Objectives : This study reports our clinicopathological experiences of major salivary gland tumors. Materials and Methods : This study included 302 patients with major salivary gland tumors who had got the diagnosis from January 1995 through December 2004. Medical records were reviewed retrospectively. Results : We found 244 benign and 58 malignant major salivary gland tumors. Among 267 parotid tumors, the most common benign parotid tumor was pleomorphic adenoma. Mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma were three most common parotid malignancies. Among 33 submandibular gland tumors, 20 cases were benign and 13 were malignant. There were one benign and one malignant sublingual gland tumors. The duration of symptom of submandibular gland tumors was longer than that of parotid tumors. Most patients presented with asymptomatic mass. Seventy-one percent of salivary gland malignancies underwent postoperative radiation therapy. Five-year disease free survival rate of parotid malignant tumors seemed to be higher than that of submandibular one, although there was no statistical significance. Conclusion : Malignancy rate of each salivary gland followed old axiom that it is inversely related with the size of gland. Submandibular gland tumor tends to be delayed to reach diagnosis. Clinicians must be alert about this finding because submandibular gland tumors are known to have poorer prognosis than parotid tumors.

Keywords

References

  1. Witt RL: Major salivary gland cancer. Surg Oncol Clin N Am. 2004;13:113-127 https://doi.org/10.1016/S1055-3207(03)00126-1
  2. Camilleri IG, Malata CM, McLean NR, Kelly CG: Malignant tumours of the submandibular salivary gland: a 15-year review. Br J Plast Surg. 1998;51:181-185 https://doi.org/10.1054/bjps.1996.0210
  3. Carlson GW: The salivary glands: embryology, anatomy, and urgical applications. Surg Clin North Am. 2000;80:261-273 https://doi.org/10.1016/S0039-6109(05)70405-9
  4. Alexander DR, Spyros Stavrianos, George Lagogiannis, Gregory Faratzis: Tumors of the submandibular gland: Clinicopathologic analysis of 23 patients. J Oral Maxillofac Surg. 2004;62:1203-1208 https://doi.org/10.1016/j.joms.2003.12.033
  5. Gallia LJ, Johnson JT: The incidence of neoplastic versus inflammatory disease in major salivary gland masses diagnosed by surgery. Laryngoscope. 1981;91:512-516 https://doi.org/10.1288/00005537-198104000-00003
  6. Walner DL, Myer CM III: Salivary gland disease. In Cummings CW, Flint PW, Harker LA, et al, editors. Otolaryngology-Head and Neck Surgery. 4th ed. St. Louis: Mosby, 2005:4116-4134
  7. Ferlito A, Pellitteri PK, Robbins KT, et al: Management of the neck in cancer of the major salivary glands, thyroid and parathyroid glands. Acta Otolaryngol. 2002;122:673-678 https://doi.org/10.1080/000164802320396385
  8. Gold DR, Annino DJ Jr: Management of the neck in salivary gland carcinoma. Otolaryngol Clin North Am. 2005;38:99-105 https://doi.org/10.1016/j.otc.2004.09.006
  9. Seifert G, Sobin LH: The World Health Organization's histological classification of salivary gland tumors. Cancer. 1992;70:379-385 https://doi.org/10.1002/1097-0142(19920715)70:2<379::AID-CNCR2820700202>3.0.CO;2-C
  10. Brandwein MS, Ferlito A, Bradley PJ, Hille JJ, Rinaldo A: Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol. 2002;122:758-764 https://doi.org/10.1080/003655402/000028047
  11. Vincent LM, Vander P: Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors. Cancer. 1999;85:2255-2264 https://doi.org/10.1002/(SICI)1097-0142(19990515)85:10<2255::AID-CNCR22>3.0.CO;2-D
  12. Vincent LM, Vander P: Stages as major long term outcome predictor in minor salivary gland carcinoma. Cancer. 2000;89:1195-1204 https://doi.org/10.1002/1097-0142(20000915)89:6<1195::AID-CNCR2>3.0.CO;2-J
  13. Kirkbride P, Liu FF, O'Sullivan B, et al: Outcome of curative management of malignant tumours of the parotid gland. J Otolaryngol. 2001;30:271-279 https://doi.org/10.2310/7070.2001.19527
  14. Bhattacharyya N: Survival and prognosis for cancer of the submandibular gland. J Oral Maxillofac Surg. 2004;62:427-430 https://doi.org/10.1016/j.joms.2003.06.012
  15. American Joint Committee on Cancer Staging: Manual for staging of cancer. 6th ed. Philadelphia, USA: J. B. Lippincott;2002